INNOVACION BIOMEDICA SL
Company details
- Active NIF/CIF: B98281397
-
-
-
-
Address: Carrer de José Pérez-Fuster Metge, 12, 46007 València, Valencia, España See in map
-
-
Featured products:
More information on INNOVACION BIOMEDICA SL
-
04/05/2021 | BORME act no.: 204316 | Register: VALENCIACierre provisional hoja registral por baja en el índice de Entidades Jurídicas
-
28/10/2011 | BORME act no.: 883795 | Register: VALENCIADepósito de cuentas anuales (Octubre de 2011)
-
17/12/2010 | BORME act no.: 465259 | Register: VALENCIAPérdida del caracter de unipersonalidad
-
17/09/2010 | BORME act no.: 355311 | Register: VALENCIAConstitución
-
17/09/2010 | BORME act no.: 355311 | Register: VALENCIADeclaración de unipersonalidad
-
17/09/2010 | BORME act no.: 355311 | Register: VALENCIANombramientos
Other information
The CIF assigned to INNOVACION BIOMEDICA SL is B98281397, and its commercial status is active. The company carries out its operations within the CNAE 7320 - Market research and public opinion polling. Likewise, its SIC code 8731 - Investigación física comercial identifies it.
INNOVACION BIOMEDICA SL employs a team of Between 1 and 9 employees and records an annual turnover of less than 2 million euros. The entity is registered in the Mercantile Registry of Valencia and has 2 registration charges. The last announcement in Borme was published on 04/05/2021, while the most recent deposit of ordinary annual accounts is from the year -.
To access the contact information of INNOVACION BIOMEDICA SL, such as the phone number, address, or website, visit the Company Data module.
If you require additional information about INNOVACION BIOMEDICA SL, you can review one of our available financial reports, the Annual Accounts of the company, or verify its default incidents in the RAI delinquency file.
All the financial, commercial, and legal information we provide about INNOVACION BIOMEDICA SL comes from official sources and is regularly updated.
Do you want to know more about INNOVACION BIOMEDICA SL??
Find out more about this company by consulting these reports: